Procter & Gamble (PG) Earnings Date & Reports

Key Takeaways

• Revenue fell short of expectations: Q4 FY2026 net sales reached $21.2 billion, up 2% year-over-year but missing the consensus estimate of approximately $21.38 billion.
• Core EPS narrowly beat estimates: Adjusted core earnings per share (EPS) came in at $1.43, edging past the analyst consensus of $1.42, though declining 3% from $1.48 in the prior-year quarter.
• Organic sales were flat: Organic sales growth — a key metric that strips out currency fluctuations, acquisitions, and divestitures — registered 0%, with volume, pricing, and mix all neutral in the quarter.
• Margins under pressure: Core operating margin contracted 130 basis points year-over-year, marking the third consecutive quarter of margin compression, driven by higher SG&A (selling, general and administrative) costs and commodity inflation.
• FY2027 guidance disappointed: Management issued fiscal 2027 core EPS guidance of $6.89 to $7.11, with a midpoint of $7.00, slightly below consensus, while projecting total sales growth of just 1% to 3%.
• Shares declined sharply: PG stock fell approximately 3% to 4% in intraday trading following the release, reflecting investor concern over the soft revenue print and cautious forward outlook.

Earnings Context and Why It Matters

Procter & Gamble's fourth-quarter fiscal 2026 results, reported on July 29, 2026, offer a critical snapshot of the consumer staples giant at a moment of heightened macroeconomic uncertainty. As one of the world's largest consumer packaged goods companies — with powerhouse brands such as Tide, Pampers, Gillette, and Crest — PG is widely viewed as a barometer for household spending patterns and global consumer health. This earnings report matters because it arrives amid sticky inflation, elevated commodity costs tied in part to geopolitical conflict, and increasingly price-sensitive shoppers who are trading down in certain categories. With full-year organic sales growth decelerating to just 1% (down from 2% in FY2025 and 4% in FY2024), investors are closely scrutinizing whether PG can reignite volume-driven growth while protecting profitability in a challenging cost environment.

Reported Results

For the fourth quarter of fiscal 2026 ended June 30, 2026, Procter & Gamble reported net sales of $21.2 billion, a 2% increase from $20.9 billion in the prior-year period. However, the top-line figure came in below the analyst consensus of approximately $21.38 billion. Foreign exchange contributed roughly one percentage point of growth, while volume, pricing, and mix had a neutral net impact — resulting in organic sales growth that was flat year-over-year.

On the earnings front, diluted net EPS under GAAP (Generally Accepted Accounting Principles) dropped 15% to $1.26, weighed down by lower gross margin and higher SG&A costs. Core EPS, which excludes certain non-recurring items, declined 3% to $1.43 but narrowly surpassed the consensus estimate of $1.42. On a currency-neutral basis, core EPS fell 5% versus the prior year. Net earnings for the quarter totaled $3.04 billion, down 16% from $3.62 billion a year ago.

Segment performance was mixed. Beauty was the standout, posting 4% organic sales growth driven by mid-single-digit gains in hair care and skin and personal care. Grooming and Fabric & Home Care were both flat on an organic basis, while Health Care declined 1%. Baby, Feminine & Family Care was the weakest segment, with organic sales down 2% as both volume and pricing slipped.

For the full fiscal year 2026, PG reported net sales of $87.0 billion (up 3%) and core EPS of $6.89 (up 1%). The company generated $19.6 billion in operating cash flow and returned over $15 billion to shareholders through $10.2 billion in dividends and $5.0 billion in share repurchases. The dividend increase in April 2026 marked the 70th consecutive year of dividend growth — one of the longest such streaks in corporate America.

AI Screener

For investors seeking to identify opportunities beyond individual earnings reports, Tickeron's AI Screener offers a powerful, AI-driven stock and ETF discovery tool. It enables traders and investors to filter thousands of securities using customizable criteria such as industry classification, market capitalization, technical indicators, price patterns, volatility metrics, and proprietary AI-generated signals. Rather than manually scanning the market, users can leverage the screener to surface breakout candidates, trending stocks, and actionable trade ideas aligned with their strategy. The tool is designed to help both retail and professional investors navigate complex markets more efficiently. Explore the AI Screener to see how data-driven insights can support your research process.

Market Reaction and Investor Sentiment

Investor reaction to PG's fourth-quarter report was decidedly negative, with shares falling roughly 3% to 4% during Wednesday's trading session. While the modest core EPS beat offered a marginal bright spot, the revenue shortfall and, more importantly, the cautious fiscal 2027 guidance dominated the narrative. The company's outlook for $1 billion in after-tax headwinds from higher raw material, energy, and transportation costs — linked in part to the ongoing conflict in the Middle East and elevated oil prices around $90 per barrel — underscored the profitability challenges ahead. With organic sales stalling and three of five business segments showing flat or negative growth, the market appeared to reassess the near-term growth trajectory for the consumer staples bellwether. The stock's decline reflected a clear message: investors are less concerned about a one-penny EPS beat and far more focused on the durability of top-line momentum and margin resilience in an inflationary environment.

Forward Outlook and Key Factors to Monitor

Looking ahead to fiscal 2027, Procter & Gamble has set expectations for organic sales growth of 1% to 3% and core EPS in the range of $6.89 to $7.11, representing flat to 3% growth versus fiscal 2026. Management signaled that the first quarter of FY2027 is likely to be the most challenging, with EPS expected to decline at least 5% year-over-year as cost headwinds intensify before easing in the second half of the fiscal year.

Several factors will shape whether PG can deliver on its guidance. The trajectory of commodity costs — particularly crude oil, which influences raw materials, energy, and transportation expenses — remains a critical variable. PG is budgeting for approximately $1 billion in after-tax commodity-related headwinds, equivalent to roughly $0.56 per share, or an 8% drag on core EPS growth.

On the demand side, consumer behavior will be equally important. With lower-income households increasingly seeking value and private-label alternatives, PG's ability to sustain pricing power and volume stability across its portfolio is under the microscope. The Beauty segment has proven resilient, but weakness in Grooming, Health Care, and Family Care warrants close attention.

Productivity initiatives will also play a central role. PG generated 340 basis points of productivity savings in fiscal 2026 and intends to fund reinvestments through continued efficiency gains. Additionally, the company's e-commerce business — which grew 6% and now represents 20% of total sales — is an area of strategic focus as digital channels reshape consumer purchasing habits. Investors should monitor quarterly organic sales trends, segment-level volume performance, and margin trajectory as the year unfolds.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations